These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31590184)

  • 21. Antibiotic Resistance: The Need For a Global Strategy.
    Elder DP; Kuentz M; Holm R
    J Pharm Sci; 2016 Aug; 105(8):2278-87. PubMed ID: 27397433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What are the economic barriers of antibiotic R&D and how can we overcome them?
    Renwick M; Mossialos E
    Expert Opin Drug Discov; 2018 Oct; 13(10):889-892. PubMed ID: 30175625
    [No Abstract]   [Full Text] [Related]  

  • 23. The drugs don't work: WHO's role in advancing new antibiotics.
    Beyer P; Moorthy V; Paulin S; Hill SR; Sprenger M; Garner S; Simão M; Guerra R; Magrini N; Swaminathan S
    Lancet; 2018 Jul; 392(10144):264-266. PubMed ID: 30064640
    [No Abstract]   [Full Text] [Related]  

  • 24. Are we seeing a resurgence in the use of natural products for new drug discovery?
    Li F; Wang Y; Li D; Chen Y; Dou QP
    Expert Opin Drug Discov; 2019 May; 14(5):417-420. PubMed ID: 30810395
    [No Abstract]   [Full Text] [Related]  

  • 25. Forging a new path. New law offers incentives to develop antibiotics.
    Lee J
    Mod Healthc; 2013 Feb; 43(5):8-9. PubMed ID: 23437480
    [No Abstract]   [Full Text] [Related]  

  • 26. Developing and sustaining India's capacity for preclinical drug discovery.
    Lewis DI; Patel BK; Kumar BD; Medhi B
    Indian J Pharmacol; 2018; 50(5):225-226. PubMed ID: 30636824
    [No Abstract]   [Full Text] [Related]  

  • 27. Ophthalmic Drug Discovery and Development.
    Gukasyan HJ; Hailu S; Karami TK
    Pharm Res; 2019 Mar; 36(5):69. PubMed ID: 30887132
    [No Abstract]   [Full Text] [Related]  

  • 28. Advancement of Technology for Drug Discovery and Development - Part II.
    Niu B
    Curr Top Med Chem; 2020; 20(1):3. PubMed ID: 31994458
    [No Abstract]   [Full Text] [Related]  

  • 29. Is one-shot learning a viable option in drug discovery?
    Baskin II
    Expert Opin Drug Discov; 2019 Jul; 14(7):601-603. PubMed ID: 30882252
    [No Abstract]   [Full Text] [Related]  

  • 30. Have nanomedicines progressed as much as we'd hoped for in drug discovery and development?
    Sarmento B
    Expert Opin Drug Discov; 2019 Aug; 14(8):723-725. PubMed ID: 31161834
    [No Abstract]   [Full Text] [Related]  

  • 31. Current Technology in the Discovery and Development of Novel Antibacterials.
    Chung PY
    Curr Drug Targets; 2018; 19(7):832-840. PubMed ID: 28891454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to rekindle drug discovery process through integrative therapeutic targeting?
    Vaidya A; Roy A; Chaguturu R
    Expert Opin Drug Discov; 2018 Oct; 13(10):893-898. PubMed ID: 30146919
    [No Abstract]   [Full Text] [Related]  

  • 33. Ensuring universal access to old antibiotics: a critical but neglected priority.
    Pulcini C; Beovic B; Béraud G; Carlet J; Cars O; Howard P; Levy-Hara G; Li G; Nathwani D; Roblot F; Sharland M
    Clin Microbiol Infect; 2017 Sep; 23(9):590-592. PubMed ID: 28522030
    [No Abstract]   [Full Text] [Related]  

  • 34. The Global Antibiotic Research and Development Partnership (GARDP): a not-for-profit antibiotic development organisation.
    Piddock LJ;
    Lancet Infect Dis; 2018 Dec; 18(12):1304-1305. PubMed ID: 30420229
    [No Abstract]   [Full Text] [Related]  

  • 35. Transforming Translation Through Quantitative Pharmacology for High-Impact Decision Making in Drug Discovery and Development.
    Gupta N; Bottino D; Simonsson USH; Musante CJ; Bueters T; Rieger TR; Macha S; Chenel M; Fancourt C; Kanodia J; Nayak S
    Clin Pharmacol Ther; 2020 Jun; 107(6):1285-1289. PubMed ID: 31709519
    [No Abstract]   [Full Text] [Related]  

  • 36. Proposals seek to reduce resistance, boost development of new antibiotics.
    Kuehn BM
    JAMA; 2011 May; 305(18):1845-6. PubMed ID: 21558509
    [No Abstract]   [Full Text] [Related]  

  • 37. The redesign of oxazolidinone antibiotics in response to Staphylococcus aureus.
    Lupton D; Belousoff MJ
    Future Microbiol; 2017 Oct; 12():1113-1117. PubMed ID: 28876083
    [No Abstract]   [Full Text] [Related]  

  • 38. How to utilize academic research efforts in cancer drug discovery.
    Bérubé G
    Expert Opin Drug Discov; 2019 Apr; 14(4):331-334. PubMed ID: 30784328
    [No Abstract]   [Full Text] [Related]  

  • 39. Model-Based Meta-Analysis: Optimizing Research, Development, and Utilization of Therapeutics Using the Totality of Evidence.
    Upreti VV; Venkatakrishnan K
    Clin Pharmacol Ther; 2019 Nov; 106(5):981-992. PubMed ID: 30993679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploitation of the Ugi-Joullié reaction in drug discovery and development.
    Gazzotti S; Rainoldi G; Silvani A
    Expert Opin Drug Discov; 2019 Jul; 14(7):639-652. PubMed ID: 31002536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.